查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447087

到 2030 年膽固醇測試市場預測：按產品類型、測試類型、分銷管道、最終用戶和地區進行的全球分析

Cholesterol Test Market Forecasts to 2030 - Global Analysis By Product Type, Test Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球膽固醇檢測市場規模將達到 68.4 億美元，預計到 2030 年將達到 135 億美元，預測期內年複合成長率為 10.3%。

膽固醇測試是一種旨在測量血液中膽固醇水平的診斷程序。評估各種類型的膽固醇，包括低密度脂蛋白 (LDL)、高密度脂蛋白 (HDL) 和三酸甘油酯，對於評估心血管健康至關重要。膽固醇測試通常透過抽血進行，以幫助識別有心臟病或經歷心血管事件風險的人。

據世界衛生組織 (WHO) 稱，到 2022 年，將有超過 6.5 億成年人患有肥胖症。

心血管疾病盛行率上升

心血管疾病，包括心臟病發作和中風，是全世界發病和死亡的主要原因。高膽固醇水平是這些疾病的主要危險因子。隨著心血管疾病盛行率持續上升，膽固醇檢測的需求也隨之增加。膽固醇測試有助於評估各種膽固醇成分的水平，包括低密度脂蛋白（LDL）膽固醇、高密度脂蛋白（HDL）膽固醇和三酸甘油酯。整體而言，心血管疾病盛行率的上升是推動市場需求的因素。

高成本

與膽固醇檢測相關的高昂費用，包括實驗室檢測、診斷設備和專業費用，造成了經濟障礙，特別是對於保險不足或無法獲得醫療保健服務的人來說。此外，醫療保健提供者還面臨著平衡提供負擔得起的測試選項的需求與保持盈利和支付營運費用的挑戰。因此，高成本對膽固醇檢測市場構成重大威脅。

技術進步

新型生物標記和多重測試平台的整合實現了全面的血脂分析，從而可以對傳統膽固醇測量之外的心血管危險因素進行更全面的評估。此外，基於實驗室的膽固醇檢測技術的進步引入了自動化分析儀和高通量系統，提高了檢測效率和擴充性，同時減少了人為錯誤和營運成本。

認知有限

許多人沒有意識到膽固醇檢測在評估心臟病和中風風險的重要性，無症狀族群的檢測率特別低。此外，對膽固醇檢測程序的誤解和錯誤訊息、感知的侵入性以及與抽血相關的不適可能會進一步阻礙人們接受檢測。因此，認知度低是限制市場拓展的主要因素。

COVID-19 的影響

COVID-19 的疫情對膽固醇檢測市場產生了負面影響。最初，醫療保健系統的重點轉向危機管理，導致常規醫療服務中斷，包括膽固醇檢測和預防性護理。許多非緊急醫療預約已被推遲或取消，導致膽固醇檢測減少。此外，出於對病毒傳播的擔憂，除非絕對必要，否則人們會避開醫療機構，這進一步減少了接受膽固醇檢測的人數。

檢測套組細分市場在預測期內將是最大的

檢測套組部分估計佔最大佔有率。這些套件通常包含在傳統實驗室之外進行膽固醇測試所需的所有組件。它通常包含試紙、採血採血針以及分析所需的溶液和試劑。醫療保健提供者還利用膽固醇檢測套組在患者就診和體檢期間進行快速評估。此外，這些套件可快速提供結果，以便及時做出介入和治療決策。

總膽固醇檢測領域預計在預測期內年複合成長率最高

預計總膽固醇檢測領域在預測期內將出現良好的成長。此測試測量血液中膽固醇的總量，包括高密度脂蛋白（HDL）膽固醇和低密度脂蛋白（LDL）膽固醇以及三酸甘油酯。總膽固醇測試在預防性醫療保健中發揮重要作用，為了解個人的血脂狀況和整體心血管健康提供了寶貴的見解。

比最大的地區

由於強大的醫療基礎設施、先進的診斷技術和心血管疾病危險因子的高盛行率，北美在預測期內佔據了最大的市場佔有率。該地區是許多製藥和生物技術公司的所在地，這些公司開發創新的降膽固醇藥物和診斷技術，推動市場成長和創新。此外，公共衛生宣傳活動和教育工作提高了人們對膽固醇管理和健康生活方式選擇重要性的認知，進一步增加了對膽固醇檢測服務和產品的需求。

年複合成長率最高的地區：

預計亞太地區在預測期內將實現盈利成長。亞太地區國家正在經歷人口變化，例如人口老化和可支配收入較高的中產階級的出現，推動了對包括膽固醇檢測在內的醫療保健服務的需求。此外，旨在解決非傳染性疾病的政府舉措，例如心血管健康促進和疾病預防計劃，正在進一步推動該地區的市場成長。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球膽固醇測試市場：依產品類型

  • 試紙
  • 檢測套組
  • 檢驗儀
  • 其他產品類型

第6章全球膽固醇測試市場：依測試類型

  • 高密度脂蛋白（HDL）膽固醇
  • 低密度脂蛋白（LDL）膽固醇
  • 總膽固醇測試
  • 三酸甘油酯/VLDL膽固醇測試
  • 其他測試類型

第7章全球膽固醇測試市場：按分銷管道

  • 在商店
  • 基於處方箋

第8章全球膽固醇測試市場：依最終用戶分類

  • 居家照護
  • 醫院和診所
  • 診斷中心
  • 其他最終用戶

第9章全球膽固醇測試市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Thermo Fisher Scientific
  • Cell Biolabs, Inc.
  • Randox Laboratories Ltd.
  • Clinical Reference Laboratory, Inc.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Alere Inc.
  • PTS Diagnostics
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Horiba Ltd
  • Danaher Corp
  • Abbott Laboratories
  • Nova Biomedical
Product Code: SMRC25348

According to Stratistics MRC, the Global Cholesterol Test Market is accounted for $6.84 billion in 2023 and is expected to reach $13.5 billion by 2030 growing at a CAGR of 10.3% during the forecast period. A cholesterol test is a diagnostic procedure aimed at measuring the levels of cholesterol in the blood. It assesses various types of cholesterol, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides, which are essential for evaluating cardiovascular health. Typically conducted through a blood sample, cholesterol testing helps identify individuals at risk of developing heart disease or experiencing cardiovascular events.

According to the World Health Organization (WHO), in 2022, over 650 million adults were obese.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular diseases

Cardiovascular diseases, including heart attacks and strokes, are leading causes of morbidity and mortality globally. High cholesterol levels are a major risk factor for these diseases. As the prevalence of cardiovascular diseases continues to rise, there is a growing need for cholesterol testing. Cholesterol testing helps in assessing the levels of different cholesterol components, such as low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. Overall, the rising prevalence of cardiovascular diseases is a factor driving market demand.

Restraint:

High cost

The high costs associated with cholesterol testing procedures, including laboratory tests, diagnostic equipment, and professional fees, can create financial barriers for individuals, particularly those without adequate insurance coverage or access to healthcare services. Moreover, healthcare providers face challenges in balancing the need to provide affordable testing options with maintaining profitability and covering operational expenses. As a result, high costs present a significant threat to the cholesterol test market.

Opportunity:

Technological advancements

The integration of novel biomarkers and multiplex testing platforms enables comprehensive lipid profiling, providing a more holistic assessment of cardiovascular risk factors beyond traditional cholesterol measurements. Furthermore, advancements in laboratory-based cholesterol testing technologies have led to the introduction of automated analyzers and high-throughput systems, enhancing testing efficiency and scalability while reducing human error and operational costs.

Threat:

Limited awareness

Many individuals remain unaware of the importance of cholesterol testing in assessing their risk of heart disease and stroke, leading to low testing rates, especially among asymptomatic individuals. Additionally, misconceptions or misinformation about cholesterol testing procedures, perceived invasiveness, or discomfort associated with blood draws may further deter individuals from seeking testing. Therefore, limited awareness is a significant factor limiting market expansion.

Covid-19 Impact

The COVID-19 pandemic had a negative impact on the cholesterol test market. Initially, the focus of healthcare systems shifted towards managing the crisis, leading to disruptions in routine medical services, including cholesterol testing and preventive care. Many non-urgent medical appointments were postponed or cancelled, resulting in a decline in cholesterol screenings. Additionally, concerns about virus transmission prompted individuals to avoid healthcare facilities unless absolutely necessary, further reducing the number of people seeking cholesterol tests.

The test kits segment is expected to be the largest during the forecast period

The test kits segment is estimated to hold the largest share. These kits typically contain all the necessary components for conducting cholesterol tests outside of traditional laboratory settings. They often include test strips, lancets for blood sampling, and solutions or reagents required for analysis. Healthcare providers also rely on cholesterol test kits for rapid assessments during patient consultations or health screenings. Additionally, these kits offer quick results, allowing for timely interventions and treatment decisions.

The total cholesterol test segment is expected to have the highest CAGR during the forecast period

The total cholesterol test segment is anticipated to have lucrative growth during the forecast period. This test measures the total amount of cholesterol present in the blood, including both high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol, along with triglycerides. The total cholesterol test plays a critical role in preventive healthcare, providing valuable insights into an individual's lipid profile and overall cardiovascular health status.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to the robust healthcare infrastructure, advanced diagnostic technologies, and a high prevalence of cardiovascular disease risk factors. The region is home to numerous pharmaceutical and biotechnology companies engaged in developing innovative cholesterol-lowering medications and diagnostic technologies, driving market growth and innovation. Additionally, public health campaigns and educational efforts raise awareness about the importance of cholesterol management and healthy lifestyle choices, further driving demand for cholesterol testing services and products.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. Countries in the Asia Pacific region are experiencing demographic shifts, including aging populations and the emergence of a middle-class segment with greater disposable income, driving demand for healthcare services, including cholesterol testing. Additionally, government initiatives aimed at addressing non-communicable diseases, including cardiovascular health promotion and disease prevention programs, further propel market growth in this region.

Key players in the market

Some of the key players in the Cholesterol Test Market include Thermo Fisher Scientific, Cell Biolabs, Inc., Randox Laboratories Ltd., Clinical Reference Laboratory, Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Alere Inc., PTS Diagnostics, Eurofins Scientific, F. Hoffmann-La Roche AG, Horiba Ltd, Danaher Corp, Abbott Laboratories and Nova Biomedical.

Key Developments:

In December 2023, Randox Laboratories Ltd and Transgene entered into a scientific collaboration, with the aim of joining their competences to deliver a novel therapeutic approach to oncology therapies.

In May 2023, Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of Indonesia (BRIN, Badan Riset dan Inovasi Nasional) to enable and enhance the country's national research and innovation infrastructure and capability.

In February 2023, Roche announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create companion diagnostics for targeted therapies, further strengthening research and innovation activities.

In November 2022, Danaher Corporation, a global science and technology innovator, announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation.

Product Types Covered:

  • Test Strips
  • Test Kits
  • Test Meters
  • Other Product Types

Test Types Covered:

  • High-Density Lipoprotein (HDL) Cholesterol
  • Low-Density Lipoprotein (LDL) Cholesterol
  • Total Cholesterol Test
  • Triglycerides/VLDL Cholesterol Test
  • Other Test Types

Distribution Channels Covered:

  • Over the Counter
  • Prescription Based

End Users Covered:

  • Homecare
  • Hospitals & Clinics
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cholesterol Test Market, By Product Type

  • 5.1 Introduction
  • 5.2 Test Strips
  • 5.3 Test Kits
  • 5.4 Test Meters
  • 5.5 Other Product Types

6 Global Cholesterol Test Market, By Test Type

  • 6.1 Introduction
  • 6.2 High-Density Lipoprotein (HDL) Cholesterol
  • 6.3 Low-Density Lipoprotein (LDL) Cholesterol
  • 6.4 Total Cholesterol Test
  • 6.5 Triglycerides/VLDL Cholesterol Test
  • 6.6 Other Test Types

7 Global Cholesterol Test Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Over the Counter
  • 7.3 Prescription Based

8 Global Cholesterol Test Market, By End User

  • 8.1 Introduction
  • 8.2 Homecare
  • 8.3 Hospitals & Clinics
  • 8.4 Diagnostic Centers
  • 8.5 Other End Users

9 Global Cholesterol Test Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Thermo Fisher Scientific
  • 11.2 Cell Biolabs, Inc.
  • 11.3 Randox Laboratories Ltd.
  • 11.4 Clinical Reference Laboratory, Inc.
  • 11.5 Quest Diagnostics Incorporated
  • 11.6 Laboratory Corporation of America Holdings
  • 11.7 Alere Inc.
  • 11.8 PTS Diagnostics
  • 11.9 Eurofins Scientific
  • 11.10 F. Hoffmann-La Roche AG
  • 11.11 Horiba Ltd
  • 11.12 Danaher Corp
  • 11.13 Abbott Laboratories
  • 11.14 Nova Biomedical

List of Tables

  • Table 1 Global Cholesterol Test Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 4 Global Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 5 Global Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 6 Global Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 7 Global Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 8 Global Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 9 Global Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 10 Global Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 11 Global Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 12 Global Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 13 Global Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 14 Global Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 15 Global Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 16 Global Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 18 Global Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 19 Global Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 20 Global Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 21 North America Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 23 North America Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 24 North America Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 25 North America Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 26 North America Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 27 North America Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 28 North America Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 29 North America Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 30 North America Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 31 North America Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 32 North America Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 33 North America Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 34 North America Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 35 North America Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 36 North America Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 37 North America Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 38 North America Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 39 North America Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 40 North America Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 41 Europe Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 43 Europe Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 44 Europe Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 45 Europe Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 46 Europe Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 47 Europe Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 48 Europe Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 49 Europe Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 50 Europe Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 51 Europe Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 52 Europe Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 53 Europe Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 54 Europe Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 55 Europe Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 56 Europe Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 57 Europe Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 58 Europe Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 59 Europe Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 60 Europe Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Asia Pacific Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 63 Asia Pacific Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 64 Asia Pacific Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 65 Asia Pacific Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 66 Asia Pacific Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 67 Asia Pacific Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 68 Asia Pacific Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 69 Asia Pacific Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 70 Asia Pacific Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 71 Asia Pacific Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 72 Asia Pacific Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 73 Asia Pacific Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 74 Asia Pacific Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 75 Asia Pacific Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 76 Asia Pacific Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 77 Asia Pacific Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 78 Asia Pacific Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 79 Asia Pacific Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 80 Asia Pacific Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 81 South America Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 83 South America Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 84 South America Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 85 South America Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 86 South America Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 87 South America Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 88 South America Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 89 South America Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 90 South America Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 91 South America Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 92 South America Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 93 South America Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 94 South America Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 95 South America Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 96 South America Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 South America Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 98 South America Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 99 South America Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 100 South America Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 Middle East & Africa Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 103 Middle East & Africa Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 104 Middle East & Africa Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 105 Middle East & Africa Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 106 Middle East & Africa Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 107 Middle East & Africa Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 108 Middle East & Africa Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 109 Middle East & Africa Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 110 Middle East & Africa Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 111 Middle East & Africa Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 112 Middle East & Africa Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 113 Middle East & Africa Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 114 Middle East & Africa Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 115 Middle East & Africa Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 116 Middle East & Africa Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 117 Middle East & Africa Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 118 Middle East & Africa Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 119 Middle East & Africa Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 120 Middle East & Africa Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)